ListarInvestigación y Desarrollo por tema "Alzheimer disease"
Mostrando ítems 41-60 de 88
-
Article
-
Article
In silico evidence of direct interaction between statins and β-amyloid (2020)
(Wiley-Liss Inc., 2019) -
Article
Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: Role of brain innate immune system (2020)
(Bentham Science Publishers B.V., 2016) -
Article
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome (2020)
(BioMed Central Ltd., 2018) -
Review
Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease? (2020)
(Bentham Science Publishers B.V., 2017) -
Review
It's all about tau (2020)
(Elsevier Ltd, 2019) -
Review
Lipid-based nanoformulations in the treatment of neurological disorders (2020)
(Taylor and Francis Ltd, 2020) -
Review
-
Review
Masitinib for the treatment of mild to moderate Alzheimer's disease (2020)
(Expert Reviews Ltd., 2015) -
Review
-
Review
-
Article
Meta-analysis of Telomere Length in Alzheimer's Disease (2020)
(Oxford University Press, 2016) -
Review
Metabolic abnormalities of erythrocytes as a risk factor for Alzheimer's disease (2020)
(Frontiers Media S.A., 2018) -
Review
-
Article
Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer's disease (2020)
(Frontiers Media S.A., 2017) -
Article
Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease (2020)
(Bentham Science Publishers B.V., 2017) -
Article
-
Review
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology (2020)
(Taylor and Francis Ltd, 2017) -
Review
-
Article